Pemro Injection 100 mg/4 ml contains Pembrolizumab, a monoclonal antibody used in cancer immunotherapy. It belongs to the class of immune checkpoint inhibitors that help the body’s immune system recognize and attack cancer cells more effectively. It is used in the treatment of several advanced or metastatic cancers under strict oncology supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Pembrolizumab
• Strength: 100 mg per 4 ml

Mechanism of Action

Pembrolizumab is a programmed death receptor-1 (PD-1) inhibitor. It blocks the interaction between PD-1 receptors on T-cells and PD-L1/PD-L2 ligands on tumor cells. By inhibiting this pathway, it restores T-cell immune activity against cancer cells, enabling the immune system to detect and destroy tumors.

Indications

Pemro Injection is indicated for:

• Non-small cell lung cancer (NSCLC)
• Melanoma (advanced or metastatic)
• Head and neck squamous cell carcinoma
• Classical Hodgkin lymphoma
• Urothelial carcinoma
• Other PD-L1 positive or MSI-H/dMMR cancers as prescribed by oncologists

Dosage and Administration

• Administered intravenously by healthcare professionals only
• Dosage and schedule depend on cancer type and treatment protocol
• Typically given every 3 or 6 weeks based on physician recommendation
• Must be used strictly under oncology supervision

Benefits

• Enhances immune system’s ability to fight cancer
• Targets multiple cancer types with PD-L1 expression
• Improves survival outcomes in advanced cancers
• May provide durable response in some patients
• Part of modern immunotherapy-based cancer treatment

Possible Side Effects

Common side effects may include:

• Fatigue
• Skin rash or itching
• Diarrhea
• Nausea
• Loss of appetite

Serious immune-related side effects may include:

• Pneumonitis (lung inflammation)
• Hepatitis
• Colitis
• Endocrine disorders (thyroid or adrenal dysfunction)

Immediate medical attention is required if severe symptoms occur.

Precautions and Warnings

• Must be used under strict oncology supervision
• Regular monitoring of liver, thyroid, and lung function is required
• Not recommended during pregnancy or breastfeeding
• Use cautiously in patients with autoimmune diseases
• Inform doctor about all current medications and medical history

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children

Conclusion

Pemro Injection 100 mg/4 ml (Pembrolizumab) is an immune checkpoint inhibitor used in the treatment of various advanced cancers. It works by enhancing the body’s immune response against tumor cells and is administered under strict oncology supervision as part of immunotherapy treatment protocols.